SNHG14

ncRNA information

ncRNA name

SNHG14

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-186/ATG14

Cancer information

Cancer name

Colorectal Cancer

Cancer site

Colon, Rectum, and Anus

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

The novel of SNHG14/miR-186/ATG14 could play a vital role in regulating CRC cell progression. Moreover, this showed its clinical potential in regulating cisplatin resistance during CRC treatment.

Tissue resource

colorectal cancer tissues and the adjacent normal tissues

human colorectal cancer cell lines SW620

human colorectal cancer cell lines SW480

normal human colon mucosal epithelial cell lines NCM460

human embryonic kidney cell lines HEK-293T

paired colorectal cancer tissues and the adjacent normal tissues

human colorectal cancer cell lines SW620

human colorectal cancer cell lines SW480

normal human colon mucosal epithelial cell lines NCM460

human embryonic kidney cell lines 293-T

Experiment

qRT-PCR,Luciferase reporter assay


Institute

the Shanghai RuiJin hospital

American Type Culture Collection

American Type Culture Collection

Country

China

USA

United States

Continent

Asia

North American

North Amercian